Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes

Journal of Microbiology, Immunology and Infection

Volumn 49, Issue 3, 2016, Pages 409-416

  Chang, Kai Ting ^a,b,c,d   Lin, Hugo You Hsien ^a,c   Kuo, Chang Hung ^a,b,c   Hung, Chih Hsing ^a,b,c,d  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

atopic dermatitis; chemokine; cytokine; tacrolimus

Indexed keywords

CCL1 CHEMOKINE; CHEMOKINE; CXCL1 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE DERIVED CHEMOKINE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TACROLIMUS; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; ADAM PROTEIN; ADAM11 PROTEIN, HUMAN; CALCINEURIN INHIBITOR; CCL1 PROTEIN, HUMAN; CCL22 PROTEIN, HUMAN; CXCL1 PROTEIN, HUMAN; CXCL10 PROTEIN, HUMAN; CYTOKINE; LIPOPOLYSACCHARIDE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; ATOPIC DERMATITIS; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INTRACELLULAR SIGNALING; MONOCYTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; CELL LINE; DERMATITIS, ATOPIC; DRUG EFFECTS; METABOLISM;

ADAM PROTEINS; CALCINEURIN INHIBITORS; CELL LINE; CHEMOKINE CCL1; CHEMOKINE CCL22; CHEMOKINE CXCL1; CHEMOKINE CXCL10; CYTOKINES; DERMATITIS, ATOPIC; HUMANS; LIPOPOLYSACCHARIDES; MONOCYTES; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS;

EID: 84991665547     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.07.006     Document Type: Article

References (44)

1. 1 Cork, M.J., Robinson, D.A., Vasilopoulos, Y., Ferguson, A., Moustafa, M., MacGowan, A., et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 118 (2006), 3–21 quiz 2–3.
2. 2 Leung, D.Y., Boguniewicz, M., Howell, M.D., Nomura, I., Hamid, Q.A., New insights into atopic dermatitis. J Clin Invest 113 (2004), 651–657.
3. 3 Mihara, K., Kuratani, K., Matsui, T., Nakamura, M., Yokota, K., Vital role of the itch-scratch response in development of spontaneous dermatitis in NC/Nga mice. Br J Dermatol 151 (2004), 335–345.
4. 4 Homey, B., Steinhoff, M., Ruzicka, T., Leung, D.Y., Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 118 (2006), 178–189.
5. 5 Terui, T., Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: overview of the pathophysiology of atopic dermatitis. J Pharmacol Sci 110 (2009), 232–236.
6. 6 Hamid, Q., Boguniewicz, M., Leung, D.Y., Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 94 (1994), 870–876.
7. 7 Fonacier, L.S., Dreskin, S.C., Leung, D.Y., Allergic skin diseases. J Allergy Clin Immunol 125 (2010), S138–S149.
8. 8 Choy, D.F., Hsu, D.K., Seshasayee, D., Fung, M.A., Modrusan, Z., Martin, F., et al. Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation. J Allergy Clin Immunol, 130, 2012 1335.e5–1343.e5.
9. 9 Moser, B., Wolf, M., Walz, A., Loetscher, P., Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25 (2004), 75–84.
10. 10 Pastore, S., Mascia, F., Mariotti, F., Dattilo, C., Girolomoni, G., Chemokine networks in inflammatory skin diseases. Eur J Dermatol 14 (2004), 203–208.
11. 11 Panina-Bordignon, P., Papi, A., Mariani, M., Di Lucia, P., Casoni, G., Bellettato, C., et al. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 107 (2001), 1357–1364.
12. 12 Leung, T.F., Ma, K.C., Hon, K.L., Lam, C.W., Wan, H., Li, C.Y., et al. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children. Pediatr Allergy Immunol 14 (2003), 296–301.
13. 13 Gros, E., Bussmann, C., Bieber, T., Förster, I., Novak, N., Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis. J Allergy Clin Immunol, 124, 2009 753.e1–760.e1.
14. 14 Campbell, J.D., Gangur, V., Simons, F.E., HayGlass, K.T., Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop. FASEB J 18 (2004), 329–331.
15. 15 Liu, M., Guo, S., Hibbert, J.M., Jain, V., Singh, N., Wilson, N.O., et al. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev 22 (2011), 121–130.
16. 16 Bechara, C., Chai, H., Lin, P.H., Yao, Q., Chen, C., Growth related oncogene-alpha (GRO-alpha): roles in atherosclerosis, angiogenesis and other inflammatory conditions. Med Sci Monit 13 (2007), RA87–RA90.
17. 17 Behniafard, N., Gharagozlou, M., Farhadi, E., Khaledi, M., Sotoudeh, S., Darabi, B., et al. TNF-alpha single nucleotide polymorphisms in atopic dermatitis. Eur Cytokine Netw 23 (2012), 163–165.
18. 18 Vicari-Christensen, M., Repper, S., Basile, S., Young, D., Tacrolimus: review of pharmacokinetics, pharmacodynamics, and pharmacogenetics to facilitate practitioners' understanding and offer strategies for educating patients and promoting adherence. Prog Transplant 19 (2009), 277–284.
19. 19 Harper, J., Smith, C., Rubins, A., Green, A., Jackson, K., Zigure, S., et al. A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis. J Invest Dermatol 124 (2005), 695–699.
20. 20 Rubins, A., Gutmane, R., Valdmane, N., Stevenson, P., Foster, C., Undre, N., Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis. J Invest Dermatol 125 (2005), 68–71.
21. 21 Mandelin, J.M., Rubins, A., Remitz, A., Cirule, K., Dickinson, J., Ho, V., et al. Long-term efficacy and tolerability of tacrolimus 0.03% ointment in infants:* a two-year open-label study. Int J Dermatol 51 (2012), 104–110.
22. 22 Rustin, M.H., The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review. Br J Dermatol 157 (2007), 861–873.
23. 23 Allen, A., Siegfried, E., Silverman, R., Williams, M.L., Elias, P.M., Szabo, S.K., et al. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 137 (2001), 747–750.
24. 24 Mu, Z., Zhao, Y., Liu, X., Chang, C., Zhang, J., Molecular biology of atopic dermatitis. Clin Rev Allergy Immunol, 2014 Apr 9 Epub http://dx.doi.org/10.1007/s12016-014-8415-1.
25. 25 Novak, N., New insights into the mechanism and management of allergic diseases: atopic dermatitis. Allergy 64 (2009), 265–275.
26. 26 Novak, N., Allam, P., Geiger, E., Bieber, T., Characterization of monocyte subtypes in the allergic form of atopic eczema/dermatitis syndrome. Allergy 57 (2002), 931–935.
27. 27 Werfel, T., The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol 129 (2009), 1878–1891.
28. 28 Mandron, M., Ariès, M.F., Boralevi, F., Martin, H., Charveron, M., Taieb, A., et al. Age-related differences in sensitivity of peripheral blood monocytes to lipopolysaccharide and Staphylococcus aureus toxin B in atopic dermatitis. J Invest Dermatol 128 (2008), 882–889.
29. 29 Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R.W., Kastelein, R.A., Bazan, F., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194 (2001), 863–869.
30. 30 Barton, G.M., Medzhitov, R., Toll-like receptor signaling pathways. Science 300 (2003), 1524–1525.
31. 31 Huang, C.H., Chu, Y.T., Kuo, C.H., Wang, W.L., Hua, Y.M., Lee, M.S., et al. Effect of procaterol on Th2-related chemokines production in human monocyte and bronchial epithelial cells. Pediatr Pulmonol 45 (2010), 977–984.
32. 32 Tsai, M.K., Jan, R.L., Lin, C.H., Kuo, C.H., Yang, S.N., Chen, H.N., et al. Suppressive effects of imidapril on Th1- and Th2-related chemokines in monocytes. J Investig Med 59 (2011), 1141–1146.
33. 33 Hung, C.H., Suen, J.L., Hua, Y.M., Chiang, W., Chang, H.C., Chen, C.N., et al. Suppressive effects of ketotifen on Th1- and Th2-related chemokines of monocytes. Pediatr Allergy Immunol 18 (2007), 378–384.
34. 34 Huang, C.H., Jan, R.L., Kuo, C.H., Chu, Y.T., Wang, W.L., Lee, M.S., et al. Natural flavone kaempferol suppresses chemokines expression in human monocyte THP-1 cells through MAPK pathways. J Food Sci 75 (2010), H254–H259.
35. 35 Wang, W.L., Kuo, C.H., Chu, Y.T., Huang, C.H., Lam, K.P., Huang, S.K., et al. Prostaglandin I(2) analogues suppress TNF-alpha expression in human monocytes via mitogen-activated protein kinase pathway. Inflamm Res 60 (2011), 655–663.
36. 36 Carr, W.W., Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations. Paediatr Drugs 15 (2013), 303–310.
37. 37 Dutta, S., Ahmad, Y., The efficacy and safety of tacrolimus in rheumatoid arthritis. Ther Adv Musculoskelet Dis 3 (2011), 283–291.
38. 38 Shimada, Y., Takehara, K., Sato, S., Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci 34 (2004), 201–208.
39. 39 Hashimoto, S., Nakamura, K., Oyama, N., Kaneko, F., Tsunemi, Y., Saeki, H., et al. Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis. J Dermatol Sci 44 (2006), 93–99.
40. 40 Kim, H.O., Cho, S.I., Chung, B.Y., Ahn, H.K., Park, C.W., Lee, C.H., Expression of CCL1 and CCL18 in atopic dermatitis and psoriasis. Clin Exp Dermatol 37 (2012), 521–526.
41. 41 Leung, T.F., Wong, G.W., Ko, F.W., Lam, C.W., Fok, T.F., Increased macrophage-derived chemokine in exhaled breath condensate and plasma from children with asthma. Clin Exp Allergy 34 (2004), 786–791.
42. 42 Medoff, B.D., Sauty, A., Tager, A.M., Maclean, J.A., Smith, R.N., Mathew, A., et al. IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J Immunol 168 (2002), 5278–5286.
43. 43 Matsuda, S., Shibasaki, F., Takehana, K., Mori, H., Nishida, E., Koyasu, S., Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation. EMBO Rep 1 (2000), 428–434.
44. 44 Dong, C., Davis, R.J., Flavell, R.A., MAP kinases in the immune response. Annu Rev Immunol 20 (2002), 55–72.